Evidence Review
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Mar 24, 2022; 13(3): 159-167
Published online Mar 24, 2022. doi: 10.5306/wjco.v13.i3.159
Evidence-based approach to the treatment of esophagogastric junction tumors
Francisco Schlottmann, María A Casas, Daniela Molena
Francisco Schlottmann, María A Casas, Department of Surgery, Hospital Alemán of Buenos Aires, Buenos Aires C1118AAT, Argentina
Daniela Molena, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States
Author contributions: Schlottmann F, Casas MA, and Molena D contributed to conception and design, acquisition of data, drafting of the article, and final approval of the version to be published.
Conflict-of-interest statement: The authors have no conflict of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Francisco Schlottmann, MD, Surgeon, Department of Surgery, Hospital Alemán of Buenos Aires, Av. Pueyrredón 1640, Buenos Aires C1118AAT, Argentina. fschlottmann@hotmail.com
Received: April 4, 2021
Peer-review started: April 4, 2021
First decision: June 4, 2021
Revised: June 14, 2021
Accepted: February 15, 2022
Article in press: February 15, 2022
Published online: March 24, 2022
Processing time: 353 Days and 10.4 Hours
Core Tip

Core Tip: Management of patients with esophagogastric junction tumors is challenging. Several surgical approaches and systemic therapies are currently available to treat these patients. This evidence-based review will help determining the optimal treatment for this complex disease.